Bayer
10:41 :
Bayer Appeals India Patent Office Ruling On Cancer-Drug License -
BANGALORE -(Dow Jones)- Germany's Bayer AG (BAYRY, BAYN.XE) has appealed against the grant of a compulsory license by India's patent authority to a local generic drug producer for its kidney- and liver-cancer medicine, Nexavar. Citing the ...
07:19 :
Eurozone crisis live: Dutch parliament to debate budget -
Dutch parliament will try to pass budget in time for 30 April deadline. • Company results in focus again in the absence of major economic data • Today's agenda8.09am: Right here is a quick round-up of today's company results across Europe. German chemical ...
08:39 :
UPDATE: Bayer's Regorafenib Improves Tumor Patients' Survival -
-- Late-stage clinical trial in patients with metastatic gastrointestinal stromal tumors meets primary endpoint -- Bayer plans to submit Regorafenib for marketing authorization in the treatment of these tumors (Adds background, analyst ...
13:27 :
Roche to offer discounted cancer drugs in India -
Roche, the world's biggest maker of cancer drugs, said it would offer 'significantly' cheaper, locally branded versions of its two cancer drugs Herceptin and MabThera by early next yearThe Swiss pharmaceutical company Roche plans to offer sharply discounted ...
15:16 :
Bayer not hungry for big acquisitions - CEO in paper -
FRANKFURT (Reuters) - German chemicals and drugs group Bayer can grow without resorting to more big M&A deals but won't shy from opportunities that emerge, Chief Executive Marijn Dekkers said in a newspaper interview.
00:54 :
FDA panel backs new Bayer stroke drug -
The recommendation on Xarelto, an anti-clotting medicine, came in spite of a contrary recommendation from the FDA’s own specialists against approving the drug
18:06 :
Bayer threatens to quit Germany over nuclear shutdown -
German companies may relocate production to countries with lower energy costsGermany's decision to phase out nuclear power after the Fukushima catastrophe in
Japan could lead to some of the country's major companies relocating elsewhere in ...
22:46 :
Bayer to outsource Betaferon production - report -
FRANKFURT (Reuters) - Bayer will outsource production of its blockbuster drug Betaferon to its rival Boehringer Ingelheim, Financial Times Deutschland said in an advance copy of its Tuesday edition.
22:00 :
Bayer to outsource Betaferon production -paper -
FRANKFURT, May 30 (Reuters) - Bayer will outsource production of its blockbuster drug Betaferon to its rival Boehringer Ingelheim, Financial Times Deutschland said in an advance copy of its Tuesday edition.
actualidad Bayer -